Hepatitis C

Using HCV-infected kidneys greatly reduces wait time for transplantation and improves survival for patients with HCV

Use of HCV-infected kidneys increased patients' quality-adjusted life expectancy.

Good Outcomes for HCV-Negative Recipients of HCV Kidneys

Good Outcomes for HCV-Negative Recipients of HCV Kidneys

Hepatitis C virus-negative recipients of HCV-infected kidneys experience HCV cure and good quality of life.

Canada Updates Guidelines for Hepatitis C Virus Infection

Canada Updates Guidelines for Hepatitis C Virus Infection

The Canadian Medical Association provided an updated evidence-based recommendations for the treatment of patients with chronic hepatitis C virus.

Blood-Brain Barrier Damage, Psychiatric Impairment in HCV Infection and Alcohol Abuse

Blood-Brain Barrier Damage, Psychiatric Impairment in HCV Infection and Alcohol Abuse

By

Alcohol use disorder in patients with HCV infection is associated with increased symptoms of depression and anxiety compared with patients with HCV and no history of alcohol abuse.

Universal Screening Best Strategy for Hepatitis C in France

Universal Screening Best Strategy for Hepatitis C in France

Universal screening is the most effective strategy for hepatitis C virus in France.

Transplanting HCV-Infected Kidneys Into HCV-Infected Patients Increased Adjusted Life Expectancy

Transplanting HCV-Infected Kidneys Into HCV-Infected Patients Increased Adjusted Life Expectancy

For patients with HCV infection with end-stage renal disease, transplant of an HCV-infected kidney followed by treatment is more cost-effective than transplant of an HCV-uninfected kidney.

Project ECHO: Educational Support to Improve Hepatitis Care

Project ECHO: Educational Support to Improve Hepatitis Care

By

Project ECHO at Los Angeles Christian Health Center contributes to improved care of HCV in underserved populations.

Direct-Acting Antivirals Effective for Hepatitis C in Seniors

Direct-Acting Antivirals Effective for Hepatitis C in Seniors

For older patients with hepatitis C virus, direct-acting antiviral therapy is effective.

Risk for Liver Cirrhosis in Methorexate-Treated Psoriasis With Chronic Viral Hepatitis

Risk for Liver Cirrhosis in Methorexate-Treated Psoriasis With Chronic Viral Hepatitis

By

Real-world data have demonstrated no rise in the development of incident liver cirrhosis among patients with psoriasis and either CHB or CHC who have received long-term MTX therapy.

Post-Transplant HCV Treatment Increases Access to Kidney Transplantation

Post-Transplant HCV Treatment Increases Access to Kidney Transplantation

Post-transplant hepatitis C treatment increases access to transplant and reduces waitlist time among hepatitis C-positive patients awaiting kidney transplantation.

Healthcare Program Obtains 93% of Prior Authorization Approvals for HCV Medications

Healthcare Program Obtains 93% of Prior Authorization Approvals for HCV Medications

By

The Respectful & Equitable Access to Comprehensive Healthcare program obtained 93% of prior authorization approvals for hepatitis C medications.

HCV Guidelines Updated to Include Recommendations for Key Populations

HCV Guidelines Updated to Include Recommendations for Key Populations

By

The guidelines were developed by the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America.

Novel Medicaid Strategy Proposed to Increase Access to HCV Treatment

Novel Medicaid Strategy Proposed to Increase Access to HCV Treatment

By

A proposed novel Medicaid purchasing strategy is anticipated to increase access to medications that can eradicate hepatitis C virus infection without increasing costs at the state and federal levels.

Two Hepatitis C Virus Infection Treatments to Be Discontinued

Two Hepatitis C Virus Infection Treatments to Be Discontinued

By

The discontinuation is voluntary and is not related to product quality, safety or efficacy.

Hepatitis C-Exposed Infants Not Adequately Screened

Hepatitis C-Exposed Infants Not Adequately Screened

Low screening rate seen at same time as increase in hepatitis C virus prevalence among pregnant women.

Real-Life Renal Outcomes With Sofosbuvir in Chronic Hepatitis C

Real-Life Renal Outcomes With Sofosbuvir in Chronic Hepatitis C

Sofosbuvir-based treatment appears to guarantee renal safety for patients with chronic hepatitis C virus over one year of follow-up.

Methadone Maintenance Therapy Associated With Greater Access to Physician Care in HCV-Positive Drug Users

Methadone Maintenance Therapy Associated With Greater Access to Physician Care in HCV-Positive Drug Users

By

The investigators suggest that enrollment in a methadone maintenance therapy program may be helpful in providing access to HCV care in people who inject drugs.

Case Report: Nephrotic Syndrome and Chronic HCV in a 72-Year-Old Woman

Case Report: Nephrotic Syndrome and Chronic HCV in a 72-Year-Old Woman

By

A 72-year-old Japanese woman with a 40-year history of lupus nephritis presented with leg edema that had lasted for several weeks.

Screening insufficient for newborns exposed to hepatitis C virus

In this retrospective study, only a fraction of infants receiving well-child care at the study institution were screened for hepatitis C, despite being born to mothers with a known history of hepatitis C virus infection.

Glecaprevir/Pibrentasvir Highly Efficacious for HCV/HIV Coinfection

Glecaprevir/Pibrentasvir Highly Efficacious for HCV/HIV Coinfection

By

Study results support the indication of glecaprevir/pibrentasvir as the first 8-week pangenotypic treatment option for HCV/HIV-1 coinfected patients without cirrhosis.

How San Francisco Is Tackling the HIV/HCV and Opioid Epidemics

How San Francisco Is Tackling the HIV/HCV and Opioid Epidemics

By

Katie Burk, MPH, presented measures undertaken by the city of San Francisco to provide integrated responses to the concurrent HIV/HCV and opioid public health epidemics.

Hepatitis C Screening Increasing Among Baby Boomers

Hepatitis C Screening Increasing Among Baby Boomers

Future research should develop interventions to increase HCV screening with special focus on groups demonstrating significantly lower screening rates, such as Hispanics and women.

Accelerated Cortical Aging With Alcohol Dependence in HCV-Infected Individuals

Accelerated Cortical Aging With Alcohol Dependence in HCV-Infected Individuals

Alcohol dependence has deleterious effects on frontal cortical volumes that are compounded by hepatitis C virus infection and drug dependence.

Hepatitis C Eradication With DAAs Improves Carotid Atherosclerosis

Hepatitis C Eradication With DAAs Improves Carotid Atherosclerosis

By

HCV eradication by DAA improves carotid atherosclerosis in patients with advanced fibrosis and compensated cirrhosis.

HCV-infected kidney donors could save lives

No HCV infection was detected in patients receiving HCV-infected kidneys 12 weeks following treatment.

Case of Psoriasis Remission After Hepatitis C Treatment

Case of Psoriasis Remission After Hepatitis C Treatment

A case of remission of psoriasis after treatment of chronic hepatitis C virus has been described.

Hepatitis C Drug Effective Against Zika Virus in Preclinical Trial

Hepatitis C Drug Effective Against Zika Virus in Preclinical Trial

By

The hepatitis C treatment, sofosbuvir was found to be effective against Zika virus in a preclinical trial.

Provider-Pharmacy Collaboration Reduces DAA Initiation Delays in HCV

Provider-Pharmacy Collaboration Reduces DAA Initiation Delays in HCV

Reduced DAA delays and denials for patients with HCV reduced with provider-pharmacy collaboration.

Statewide Increase in Hepatitis C Virus Vertical Transmission Found

Statewide Increase in Hepatitis C Virus Vertical Transmission Found

By

State medical surveillance data suggest that the risk for mother-to-infant vertical transmission of hepatitis C virus is increasing.

Treatment Regimens and Recommendations for HIV/HCV Coinfection

Treatment Regimens and Recommendations for HIV/HCV Coinfection

By

Experts discuss the management of drug-drug interactions in patients receiving treatment for HIV and HCV coinfection.

Sign Up for Free e-newsletters